Silk, Cells, and Sudden Swings
DENVER, Colo., Sep 26, 2025 (247marketnews.com)- A surge of midday catalysts is shaking up the narket with biotech breakthroughs, energy innovation, and rare material milestones fueling sharp moves, and potentially bigger stories into the close.
Shares of Kraig Biocraft Laboratories (OTCQB:KBLB) are weaving serious momentum after the company successfully completed its first simultaneous dual-facility production cycle, a key leap in its effort to industrialize recombinant spider silk.
CEO Kim Thompson called the milestone a “transformative step,” signaling a potential shift from R&D to commercial readiness. With fiber deliveries to a global fashion house and potential partners in sportswear on deck, bulls are watching Q4 closely for revenue validation.
KBLB has long pursued scalable spider silk production, a technically elusive feat, and this dual-site success could represent a proof-of-platform moment.
Plus Therapeutics (NASDAQ:PSTV) remains in focus following yesterday’s business update on CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics that it signed a national agreement with UnitedHealthcare Insurance Company (NYSE:UNH), covering over 51 million Americans, to provide the CNSide Cerebrospinal Fluid Tumor Cell Enumeration laboratory developed test (LDT).
Curanex Pharmaceuticals (NASDAQ:CURX) is moving on speculative volume today as chatter builds around potential updates to its orphan drug development program. The company is advancing therapies for ultra-rare inflammatory and neurodegenerative diseases, with preclinical data expected later this quarter.
Biotech investors have been rotating into names with tight floats and late-stage pipeline assets, and CURX’s low share structure could become a magnet if the company delivers even early signals of efficacy or regulatory movement.
Applied Therapeutics (NASDAQ:APLT) is quietly gaining midday as investors anticipate further data and commercial updates around Govorestat, the company’s experimental therapy for Galactosemia and other metabolic disorders.
Having received FDA Fast Track and Orphan Drug Designations, APLT is working toward NDA submission by early 2026, but recent pipeline clarity and partnership rumors have kept traders engaged in the near term.
Fintech player Cardlytics (NASDAQ:CDLX) is ticking upward as rumors swirl about potential new banking integrations for its purchase intelligence platform, which helps advertisers target users based on real transaction data.
Cardlytics has faced heavy volatility in recent months, but with cost-cutting already executed and a focus on margin improvement, bulls are watching for signs of a top-line growth reacceleration in the back half of the year.
Complete Solaria (NASDAQ:CSLR) is in the picture as investors rotated back into clean energy microcaps. The company, which specializes in residential solar design and financing, has recently been linked to potential consolidation within the fragmented U.S. rooftop market.
CSLR’s backlog visibility and ongoing cost-optimization efforts could appeal to investors seeking post-selloff rebound candidates in the solar-as-a-service segment.
Dragonfly Energy (NASDAQ:DFLI) is extending gains from earlier in the week after management confirmed that it is in active talks with multiple commercial vehicle OEMs for integrating its solid-state lithium battery systems.
As legacy auto players face pressure to electrify without heavy infrastructure shifts, Dragonfly’s drop-in replacement model continues to attract interest. The company’s platform offers lithium-powered retrofits that reduce both maintenance costs and carbon footprints.
New Era Helium (NASDAQ:NEON), one of the few public pure-play helium exploration companies, saw a midday pop as helium pricing continues to climb due to supply chain restrictions and growing demand from semiconductors, MRIs, and space tech.
The company recently completed exploratory testing at its New Mexico-based field and is on track to deliver initial production guidance by Q1 2026. Investors are watching closely as helium becomes a strategic material with national importance.
Little-known Harrison Global (NASDAQ:HGLH), a real estate tech and services firm, is spiking midday after speculation that the company is preparing to license its AI-powered property valuation engine to institutional REITs and alternative asset managers.
If confirmed, the move could significantly expand revenue visibility in a space long dominated by manual appraisals and outdated modeling. Investors are eyeing upcoming SEC filings and conference appearances for potential confirmation.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
CONTACT:
24/7 Market News
Editor@247marketnews.com